COVVI-19 Vaccination in Pregnant Women
- PARIS – A recent national study in France examined COVID-19 vaccination rates among pregnant women, revealing disparities compared to the general population, especially during critical phases of the...
- The research, leveraging data from the Epi-Meres register encompassing 1,203,454 women who gave birth in France between April 2021 and December 2022, sought to evaluate vaccination uptake and...
- The study found that 52% of pregnant women received at least one dose of a COVID-19 vaccine.
COVID-19 Vaccination Rates Among Pregnant Women in France Analyzed
PARIS – A recent national study in France examined COVID-19 vaccination rates among pregnant women, revealing disparities compared to the general population, especially during critical phases of the pandemic.
Study Overview
The research, leveraging data from the Epi-Meres register encompassing 1,203,454 women who gave birth in France between April 2021 and December 2022, sought to evaluate vaccination uptake and identify associated factors. Vaccination rates were standardized by age and social index for comparison with the general female population. Multivariable logistic regression was used to assess associations with socio-demographic factors, pregnancy monitoring indicators, and pre-existing health conditions.
Key Findings
The study found that 52% of pregnant women received at least one dose of a COVID-19 vaccine. Of those vaccinated, 62.1% received their frist dose before conception, while 8.2%, 20.9%, and 8.8% were vaccinated during the first,second,and third trimesters,respectively.
Initially, vaccination rates among pregnant women lagged behind those of the general population. However, the rates converged by June 2022, reflecting a six-month delay. Younger women and those from socially disadvantaged backgrounds exhibited lower vaccination rates.
The study also indicated that unvaccinated women were more likely to be in their third pregnancy (Adjusted Odds Ratio (AOR), 1.21 [1.19-1.22]),undergo fewer ultrasounds (AOR,0.71 [0.70-0.73]), and less frequently take folic acid (AOR, 0.73 [0.72-0.74]).
Conversely, women with pre-existing conditions such as obesity, diabetes, hypertension, those using antidepressants, or those with chronic respiratory disease, were less likely to remain unvaccinated (AOR between 0.69 and 0.89).
Conclusions and Implications
researchers concluded that while pregnant women in France eventually reached similar vaccination rates to the general population, they were initially less well-vaccinated during critical periods of the pandemic. Socio-economic status and the extent of prenatal care were strongly linked to lower vaccination rates.
The study authors suggest that these findings warrant future interventions and policy adjustments to address vaccination disparities within this population segment.
COVID-19 Vaccination During pregnancy: A Q&A
This article provides a comprehensive overview of a recent study analyzing COVID-19 vaccination rates among pregnant women in France. We’ll explore key findings,potential implications,and address frequently asked questions.
What was the main focus of the study?
The primary objective of the study was to examine COVID-19 vaccination rates among pregnant women in France and identify any disparities compared to the general population, notably during critical phases of the pandemic. The research aimed to understand vaccination uptake and the factors associated wiht it.
How was the study conducted?
The study utilized data from the Epi-meres register, which included data from 1,203,454 women who gave birth in France between April 2021 and December 2022. Researchers assessed vaccination rates and compared them with the general female population, standardizing for age and social index. They also used multivariable logistic regression to evaluate the relationships between vaccination and various factors such as socio-demographic characteristics, pregnancy monitoring indicators, and pre-existing health conditions.
What where the main findings regarding vaccination rates?
The study revealed that 52% of pregnant women received at least one dose of a COVID-19 vaccine. Among those vaccinated:
- 62.1% received their first dose before conception.
- 8.2% were vaccinated during the first trimester.
- 20.9% were vaccinated in the second trimester.
- 8.8% were vaccinated in the third trimester.
Did vaccination rates among pregnant women differ from the general population?
Initially, vaccination rates among pregnant women lagged behind those of the general population. However, the study found that the rates converged by June 2022, with approximately a six-month delay between the two groups.
What factors were associated with lower vaccination rates?
The study indicated that younger women and those from socially disadvantaged backgrounds had lower vaccination rates. Also, unvaccinated women were more likely to be in their third pregnancy, undergo fewer ultrasounds, and less frequently take folic acid.
Were any pre-existing health conditions linked to vaccination status?
Yes. Women with pre-existing conditions such as obesity, diabetes, hypertension, those using antidepressants, or those with chronic respiratory disease were less likely to remain unvaccinated.
What are the key implications of the study’s findings?
The study’s findings suggest that while pregnant women in France eventually reached similar vaccination rates to the general population, they were initially less well-vaccinated during crucial periods of the pandemic. Socio-economic factors and the quality of prenatal care were strongly associated with lower vaccination rates. These findings highlight the need for future interventions and policy adjustments aimed at addressing vaccination disparities within this population segment.
Can you summarize the key differences between vaccinated and unvaccinated women based on the study?
Here’s a summarized comparison:
| Factor | Unvaccinated women | Vaccinated Women |
|---|---|---|
| Pregnancy | More likely to be in their third pregnancy (AOR: 1.21 [1.19-1.22]) | – |
| Prenatal Care | Underwent fewer ultrasounds (AOR: 0.71 [0.70-0.73]), Less likely to take folic acid (AOR: 0.73 [0.72-0.74]) | – |
| Pre-existing conditions | Less likely to have pre-existing conditions like obesity, diabetes, hypertension, or chronic respiratory diseases. | More likely to have pre-existing conditions like obesity, diabetes, hypertension, or chronic respiratory diseases (AOR between 0.69 and 0.89) |